An adenomatous polyp, also known as an adenoma, is an abnormal growth of cells that forms on the colon's lining. These polyps are common, comprising around 70% of all colon polyps. Roughly one ...
Receiving the FDA’s clearance to proceed with our Phase 2 clinical trial for TPST-1495, our second clinical program, in FAP marks an important step forward in developing new treatment options for ...
The trial will focus on patients with Familial Adenomatous Polyposis (FAP), indicating the company is addressing urgent medical needs in a high-risk patient population. This initiative is ...
Biodexa Pharmaceuticals has announced that the US FDA has granted Fast Track designation for its drug eRapa, an encapsulated form of rapamycin, which is being developed for familial adenomatous ...
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP Biodexa is finalizing plans to initiate an international Phase 3 ...
The planned Phase 2 study will evaluate the efficacy and safety of TPST-1495 in patients with Familial Adenomatous Polyposis (FAP) who have previously undergone colectomy. The primary efficacy ...